Author

Thandeka Moyo-Gwete

National Center for Disease ControlORCID 0000-0002-4269-9281Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Assay:DNA methylation· 1 Assay:proteomics· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Nonhlanhla N. MkhizeiD· 2 shared Penny L. MooreiD· 2 shared Alaine A. MarsdeniD· 1 shared Alec P. PankowiD· 1 shared Alex SigaliD· 1 shared Allan C. deCampiD· 1 shared Anna patjane· 1 shared Anna YsseliD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Nonhlanhla N. MkhizeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Low seroprevalence of neutralizing antibodies to gorilla adenovirus 32 (GRAd32) in southern African populations supports evaluation of this vector platform for HIV vaccine development

Nonhlanhla N. Mkhize, Anna patjane, Nomcebo Shusha, Ashleigh Welsh, Tandile Hermanus, Prudence Kgagudi, Thopisang P. Motlou, Linda‐Gail Bekker, Glenda Gray, Nigel Garrett, Lee Fairlie, Alex Sigal, Wendy A. Burgers, Takudzwa Mangwaku, Tariro Makadzange, , Penny L. Moore

This study finds low neutralizing antibody prevalence to GRAd32 in southern African populations, suggesting its potential as an HIV vaccine vector despite prior Ad26 vaccination.

bioRxiv · May 26, 2026 · PreprintImmunology

VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials

Carolyn E. Williamson, Lyle Curry, Nonhlanhla N. Mkhize, Elena E. Giorgi, Craig A. Magaret, Bronwen E. Lambson, Sinethemba Bhebhe, Haajira Kaldine, Thandeka Moyo-Gwete, Morgane Rolland, Raabya Rossenkhan, Nina Marie G. Garcia, Chivonne Moodley, Anna Yssel, Yunda Huang, , James I. Mullins

This study identifies VRC01-mediated viral escape mutations in HIV-infected participants from antibody-mediated prevention trials, showing that VRC01 can select for escape variants with cross-resistance to other CD4bs bnAbs.

bioRxiv · Oct 29, 2025 · PreprintMicrobiology